TTR and visceral leishmaniasis: These derivatives possessed different inhibitory activities against cancer cells, Trypan osoma brucei [24] and Visceral Leishmaniasis [25], and selectively targeted tyrosine kinase [26], proteasome [25], and transthyretin amyloidogenesis [27].